← Back to Search

Mobile Cognitive Behavioral Therapy for Anxiety and Depression

N/A

Recruiting

Led By Patricia Marino

Research Sponsored by Weill Medical College of Cornell University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to endpoint [week 6]

Awards & highlights

No Placebo-Only Group

Summary

This trial tests if adding a mobile app to regular therapy sessions helps young adults with anxiety and depression more than just therapy alone. The app is used to practice therapy exercises, making it easier for patients to manage their symptoms.

Who is the study for?

This trial is for medical and graduate students aged 18-40 at Weill Cornell Medicine who are experiencing significant anxiety or depression, as indicated by specific scores on recognized scales. It's not open to those with a history of bipolar or psychotic disorders, or current severe suicidal intentions.

What is being tested?

The study compares two approaches: standard clinician-delivered cognitive behavioral therapy (CBT) versus CBT with the addition of 'MAYA', a mobile app designed to support mental health. Participants will use MAYA twice weekly alongside regular CBT sessions and complete weekly self-assessments.

What are the potential side effects?

While using the MAYA app isn't expected to have physical side effects, participants may experience emotional discomfort when confronting difficult thoughts or feelings during cognitive behavioral therapy exercises.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to endpoint [week 6]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to endpoint [week 6]

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to endpoint [week 6] for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in anxiety symptoms from baseline to end of treatment as measured by the GAD-7.

Change in depressive symptoms from baseline to end of treatment as measured by the PHQ-9

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Clinician-delivered CBT + Supplemental appExperimental Treatment2 Interventions

Mobile application at least two times per week for six weeks, for at least 20 minutes on each of the two days in addition to the clinician-delivered CBT

Group II: Clinician-delivered Cognitive Behavioral Therapy onlyActive Control1 Intervention

Participants receive treatment with a licensed clinician for 6 weeks.

Do I qualify?Apply below to find out